SUBSCRIBE
SUBSCRIBE
News   Business

Irish Drugmaker Elan Corporation PLC Suffers $43.6M Net Loss In Q3

October 27, 2010 | 
1 min read
DUBLIN, Oct 27 (Reuters) - Irish drugmaker Elan Corp Plc (ELN.I) said on Wednesday it expected to make underlying earnings before interest, tax, depreciation and amortisation (EBITDA) of over $150 million in the current year.
Earnings Europe
MORE ON THIS TOPIC
Businessman receiving large stacks of money from a giant hand. Concept of funding, venture capital, financial support, dividend, and profitable business.
Funding
Teva Bags $400M Backing From Blackstone To Advance Sanofi-Partnered Drug
March 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Handmade signboard with Closed inscription and striped rope hanging on pin on bright red background
Company closure
Bespoke Startup EveryONE Folds 1 Week After Plausible Mechanism Guidance
March 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Theravance Halves Headcount, Cans R&D Work After Phase 3 Fail
March 4, 2026
 · 
61 min read
 · 
BioSpace Editorial Staff
Halftone hands reaching for money. Mixed media catch falling coins and cash bills collage, financial success, free wealth and easy money concept vector illustration
Earnings
Keytruda Hangs On to Best Seller Crown as GLP-1s Gain Ground
March 4, 2026
 · 
9 min read
 · 
Tristan Manalac